Thomas Blinka

Of Counsel

I leverage my background in chemistry and pharmaceuticals to help life sciences clients monetize their intellectual property assets.

Tom Blinka is an of counsel focused on patent procurement and counseling relating to chemical technologies, with a particular focus on small molecule pharmaceuticals, pharmaceutical compositions and methods of treatment. Tom brings to his client engagements his experience as a researcher/inventor for more than a decade and his in-depth knowledge of chemistry that has been deepened through 25+ years of industry and academic experience.

Download full bio 


  • Obtained the first US patents covering combination HIV therapies for Gilead Sciences 

  • Cardioxyl Pharmaceuticals sale to Bristol-Myers Squibb 

  • Global cross-license achieved for Gevo in long-running biofuels patent case 

  • Kyle Bass’ attacks on multiple Horizon Pharma patents is blocked 

  • Vitae Pharmaceuticals Completes Initial Public Offering  

  • View all


  • The Catholic University of America, Columbus School of Law
    JD, ABA – BNA Award for Excellence in the Study of Intellectual Property Law, 2002

  • University of Wisconsin-Madison
    Ph.D., Organic Chemistry, 1985

  • Cornell University
    BA, Chemistry, 1979

Admissions & Credentials

District of Columbia

Registered to practice before the United States Patent & Trademark Office (USPTO)



  • American Bar Association

  • New Jersey Intellectual Property Law Association

Rankings & Accolades

    Legal 500: Patent Prosecution


US patents from over 13 years of industrial research experience